Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Lyndsey Runaas MD
Assistant Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
08/2002 - 05/2006 BA, Ithaca College, Ithaca, NY
08/2006 - 05/2010 MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/2010 - 06/2013 Residency, Medicine, Internal Medicine, University of Wisconsin, Madison, WI
06/2013 - 06/2014 Chief Resident, Medicine, Internal Medicine, University of Wisconsin, Madison, WI
07/2014 - 06/2017 Fellow, Medicine, Hematology and Oncology, University of Michigan, Ann Arbor, MI

FACULTY APPOINTMENTS:
06/2013 - 06/2014 Vogelman/Carnes Family Endowed Chief Resident, Medicine, Internal Medicine, University of Wisconsin, Madison, WI
08/2017 - 06/2018 Instructor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
04/2018 - 09/2020 Assistant Professor, Internal Medicine, Hematology-Oncology, Clement J. Zablocki VA Medical Center, Milwaukee, WI
07/2018 - Present Assistant Professor, Internal Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
07/01/2019 - 07/01/2021 Associate Program Director, Hematology and Oncology Fellowship, Internal Medicine, Hematology and Oncology
07/01/2021 - Present Program Director, Internal Medicine, Hematology and Oncology, Medical College of Wisconsin

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
06/2013 - 06/2014 Hospitalist, Stoughton Hospital, Stoughton, WI

SPECIALTY BOARDS AND CERTIFICATION:
Licensure
Number Issue DateExpiration
Medical License
56667-20
2012
10/2021
 

AWARDS AND HONORS:
08/2002 - 05/2006 Park Scholarship, Park Foundation
2009 - Present Inducted into Alpha Omega Alpha
2013 - Present Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award, American Society of Hematologists

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2013 - Present American Society of Hematology
2014 - Present American Society of Clinical Oncology
2015 - Present American Society for Blood and Marrow Transplantation

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
06/2018 - Present Member, BMT CTN 1704 Protocol Committee

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Oligosaccharide supplementation among Clostridium difficile Hematology-Oncology patients
Role:
Co-Investigator
PI:
Silvia Munoz-Price
Dates:
08/2018 - Present
Direct Funds:
$50,000
 
Title:
A Phase II Trial of Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
Role:
PI
PI:
Lyndsey Runaas, Bill Drobyski
Dates:
09/2018 - Present
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Regional
Evolving Landscape in AML Treatment: Moving Beyond 3+7?, 7th Annual Controversies in Hematologic Malignancies, Milwaukee, WI, 03/03/2018
Moving Beyond 3+7 in AML: Are we There Yet?, Wisconsin Oncology Network Meeting -- Keynote address, Madison, WI, 03/16/2019
Bone Marrow Transplantation: Risks and Benefits, Aplastic Anemia and MDS International Foundation 2019 Patient & Family Conference, Milwaukee, WI, 07/20/2019 - Present
 
National
Treatment of Hematologic Malignancies: Targeted Therapy for Acute Myeloid Leukemia, OncLive State of the Science Summit, Brookfield, WI, 04/08/2019
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
International
Invited poster discussant -- Hematologic Malignancies -- Leukemia, Myelodysplastic Syndromes and Allotransplant., ASCO 2019, Chicago, IL, 06/03/2019
 

COMMITTEE SERVICE:
Medical College of Wisconsin
08/01/2018 - Present Committee Member, Cancer Service Line IT EPIC Provider Stakeholder Group, Hematology and Oncology, Medicine, Medical College of Wisconsin
09/01/2018 - Present Member, Scientific Review Committee, Hematology and Oncology, Medicine
08/01/2019 - 06/30/2020 Member, Medical School Admissions Committee, Medical College of Wisconsin
06/2020 - Present Committee Member, Innovative Therapies Committee, Medical College of Wisconsin
 
Hospital
06/14/2019 - Present Committee Member, Accountable Care Team -- 8CFAC, Hematology-Oncology, Internal Medicine, FMLH
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Community/Lay Public
03/05/2018 - Present MDS Talk
 
Medical Student Education
01/05/2018 - Present AML talk for hematology/oncology fellows
08/2018 - 10/2018 Clinical Faculty for Molecules to Cells Course
03/13/2019 - Present M3 Student Advising
 
Resident and Fellow Education
06/13/2018 - Present Acute Leukemia Talk for PGY1s
03/2021 - Present BMT Talk for Fellows
 

EXTRAMURAL TEACHING:
Resident and Fellow Education
04/2018 - 10/2019 Clement J. Zablocki VA Medical Center, Oversee fellows clinic at VA
06/10/2019 St. Joseph's Hospital, Acute Leukemia Talk for Residents
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Faculty
09/2018 - 06/2019 Participated in a year long program to develop knowledge and skills in curriculum development as part of a peer mentoring program through the department of medicine.
 
Research Programs
09/2018 - Present Innovation Fellowship Program: Program designed to foster a culture of innovation throughout the department of medicine and connect the work of Inception Health with our divisions.
 
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Runaas L, Hanauer D, Maher M, Bischoff E, Fauer A, Hoang T, Munaco A, Sankaran R, Gupta R, Seyedsalehi S, Cohn A, An L, Tewari M, Choi SW. BMT Roadmap: A User-Centered Design Health Information Technology Tool to Promote Patient-Centered Care in Pediatric Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2017 May;23(5):813-819. PMCID: PMC7293064
2. Magenau J, Runaas L, Reddy P. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol. 2016 Apr;173(2):190-205.
3. Cook RJ, Runaas LN. The Difficulties of Informed Consent in Stem Cell Transplant. Curr Hematol Malig Rep. 2016 Feb;11(1):1-5.
4. Lyndsey Runaas Flora Hoodin Anna Munaco Alex Fauer Roshun Sankaran Tracey Churay Saara Mohammed Sajjad Seyedsalehi Grant Chappell Noelle Carlozzi Michael D. Fetters Rachel Kentor Leah McDiarmid Kristina Brookshire Casiana Warfield Michelle Byrd Sharon Kaziunas Molly Maher John Magenau Larry An Amy Cohn David A. Hanauer Sung Won Choi. Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes JCO Clinical Cancer Informatics. DOI: 10.1200/CCI.17.00110 JCO Clinical Cancer Informatics - published online January 11, 2018.
5. Fauer AJ, Hoodin F, Lalonde L, Errickson J, Runaas L, Churay T, Seyedsalehi S, Warfield C, Chappell G, Brookshire K, Chaar D, Shin JY, Byrd M, Magenau J, Hanauer DA, Choi SW. Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients. Support Care Cancer. 2019 Jun;27(6):2103-2112. PMCID: PMC6431273
6. Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biol Blood Marrow Transplant. 2019 04;25(4):827-833.
7. Runaas L, Hoodin F, Munaco A, Fauer A, Sankaran R, Churay T, Mohammed S, Seyedsalehi S, Chappell G, Carlozzi N, Fetters MD, Kentor R, McDiarmid L, Brookshire K, Warfield C, Byrd M, Kaziunas S, Maher M, Magenau J, An L, Cohn A, Hanauer DA, Choi SW. Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes. JCO Clin Cancer Inform. 2018 12;2:1-12. PMCID: PMC6873938
8. Abedin S, McKenna E, Chhabra S, Pasquini M, Shah NN, Jerkins J, Baim A, Runaas L, Longo W, Drobyski W, Hari PN, Hamadani M. Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 08;25(8):1689-1694.
9. Magenau J, Braun T, Gatza E, Churay T, Mazzoli A, Chappell G, Brisson J, Runaas L, Anand S, Ghosh M, Riwes M, Pawarode A, Yanik G, Reddy P, Choi SW. Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2019 08;25(8):1682-1688.
10. Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database. J Natl Compr Canc Netw. 2020 02;18(2):169-175.
11. George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study Leukemia Research. July 2020;94.
12. Abid MB, Hamadani M, Szabo A, Hari PN, Graham MB, Frank MO, Collier WS, Abedin S, Jerkins JH, Pasquini MC, Runaas L, Shah NN, Chhabra S. Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation. Biol Blood Marrow Transplant. 2020 09;26(9):1670-1678.
13. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 10;26(10):1876-1885. PMCID: PMC7571859
14. George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase-A real world study. Leuk Res. 2020 07;94:106368.
15. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885] (Biology of Blood and Marrow Transplantation (2020) 26/10(1876-1885) (S1083879120304146), (10.1016/j.bbmt.2020.07.005)) Transplantation and Cellular Therapy. 2021.
 
Books, Chapters, and Reviews
1. Blood and Marrow Transplant Handbook Comprehensive Guide for Patient Care, third edition. Engraftment and Graft Failure. Co-Authors: P Hari, S. Chhaubra